2.5600
-0.0800
(-3.03%)
At close: January 17 at 5:38:02 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ian Crosbie | CEO & Executive Director | 440.57k | -- | -- |
| Ms. Kirsten Van Bockstaele | Chief Financial Officer | 355.98k | -- | 1975 |
| Ms. Lies Vanneste | Director of Investor Relations | -- | -- | -- |
| Mr. Gijs Klarenbeek M.D. | MD & Chief Medical Officer | -- | -- | 1977 |
| Mr. Martijn Blom | Chief Commercial Officer | -- | -- | 1974 |
Sequana Medical NV
Kortrijksesteenweg 1112
box 102 Sint-Denijs-Westrem
Gent, 9051
Belgium
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 62
Description
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Corporate Governance
Sequana Medical NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
IBAB.BR Ion Beam Applications SA
12.74
-0.93%
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
ALCAR.PA Carmat SA
1.0700
-3.08%
MCAP.ST MedCap AB (publ)
411.00
-29.98%
KURN.SW Kuros Biosciences AG
22.20
-4.52%
ZIMV ZimVie Inc.
14.29
+1.71%
IOB.DU Ion Beam Applications SA
12.98
-2.41%
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
CXT.BE Carmat
1.0680
-3.26%